Results 11 to 20 of about 5,912 (202)

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection [PDF]

open access: yesBMC Urology, 2015
BACKGROUND: In this study, we further investigated the association of two biomarkers, CCL18 and A1AT, with bladder cancer (BCa) and evaluated the influence of potentially confounding factors in an experimental model. METHODS: In a cohort of 308 subjects (
Alcaraz Asensio, Antonio   +9 more
core   +6 more sources

The Utilization of Alpha 1 Anti-trypsin (A1AT) in Infectious Disease Monitoring and Treatment.

open access: yesJournal of Microbiology and Infectious Diseases, 2019
Alpha one anti-trypsin (A1AT) is a major serine protease inhibitor found circulating in human blood. A1AT related studies mainly focus on A1AT potential biomarker as well as therapeutic target in non-infectious diseases.
Irene Lorinda Indalao   +5 more
doaj   +4 more sources

Alpha1-antitrypsin counteracts heme-induced endothelial cell inflammatory activation, autophagy dysfunction and death

open access: yesRedox Biology, 2021
Free heme toxicity in the vascular endothelium is critical for the pathogenesis of hemolytic disorders including sickle cell disease. In the current study, it is demonstrated that human alpha1-antitrypsin (A1AT), a serine protease inhibitor with high ...
Kukuh Madyaningrana   +10 more
doaj   +1 more source

Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression. [PDF]

open access: yesPLoS ONE, 2017
The main goal of the therapy with purified human plasma alpha1-antitrypsin (A1AT) is to increase A1AT levels and to prevent lungs from elastolytic activity in patients with PiZZ (Glu342Lys) A1AT deficiency-related emphysema.
Ahmad Karadagi   +14 more
doaj   +1 more source

Active trafficking of alpha 1 antitrypsin across the lung endothelium. [PDF]

open access: yesPLoS ONE, 2014
The homeostatic lung protective effects of alpha-1 antitrypsin (A1AT) may require the transport of circulating proteinase inhibitor across an intact lung endothelial barrier.
Angelia D Lockett   +13 more
doaj   +1 more source

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency? [PDF]

open access: yesPLoS ONE, 2015
The Z deficiency in α1-antitrypsin (A1ATD) is an under-recognized condition. Alpha1-antitrypsin (A1AT) is the main protein in the α1-globulin fraction of serum protein electrophoresis (SPE); however, evaluation of the α1-globulin protein fraction has ...
Ilaria Ferrarotti   +14 more
doaj   +1 more source

Impact of serine protease inhibitor alpha1-antitrypsin on expression of endoplasmic reticulum stress-induced proinflammatory factors in adipocytes

open access: yesBiochemistry and Biophysics Reports, 2021
Obesity-induced endoplasmic reticulum (ER) stress contributes to low-grade chronic inflammation in adipose tissue and may cause metabolic disorders such as diabetes mellitus and dyslipidemia.
Yukari Ando   +5 more
doaj   +1 more source

Development and characterization of a new human hepatic cell line [PDF]

open access: yes, 2015
The increasing demand and hampered use of primary human hepatocytes for research purposes have urged scientists to search for alternative cell sources, such as immortalized hepatic cell lines.
Berx, Geert   +6 more
core   +4 more sources

Optimal alpha-1 antitrypsin level cutoffs for genotype identification in patients with chronic liver disease

open access: yesHepatology Communications, 2023
Background:. Controversy exists whether alpha-1 antitrypsin (A1AT) genotype testing should be performed as a first-line screening for A1AT heterozygous variants. Methods:.
Sameer Prakash, Arvind R. Murali
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy